Bristol Myers will pay up to $5.8 billion for cancer treatment specialists Mirati Therapeutics in the last oncology deal in the fast-moving pharma sector.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Bristol Myers to buy cancer specialists Mirati Therapeutics for $5.8 billion